Porfimer Sodium in Diagnosing Patients With Head and Neck Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs that make cancer cells more visible to light may help in the diagnosis of
head and neck cancer.
PURPOSE: Phase II trial to study the usefulness of porfimer sodium in diagnosing patients
with head and neck cancer.